...
首页> 外文期刊>Basic & clinical pharmacology & toxicology. >Reduction of hippocampal apoptosis by intracerebroventricular administration of extracellular signal-regulated protein kinase and/or p38 inhibitors in amyloid beta rat model of Alzheimer's disease: involvement of nuclear-related factor-2 and nuclear factor-κB.
【24h】

Reduction of hippocampal apoptosis by intracerebroventricular administration of extracellular signal-regulated protein kinase and/or p38 inhibitors in amyloid beta rat model of Alzheimer's disease: involvement of nuclear-related factor-2 and nuclear factor-κB.

机译:在阿尔茨海默氏病的淀粉样β大鼠模型中,通过脑室内给予胞外​​信号调节蛋白激酶和/或p38抑制剂来减少海马凋亡:核相关因子2和核因子κB的参与。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study, we examined the effects of intracerebroventricular administration of extracellular signal-regulated protein kinase- (ERK) and p38-specific inhibitors, U0126 and PD169316, respectively, on apoptosis induced by amyloid beta (Aβ) in rats. To investigate the effects of these compounds, we evaluated intracellular signalling pathways of apoptosis, as well as inflammatory and antioxidant pathways, 7 and 20 days after Aβ injection. We found that caspase-3 and Bax/Bcl-2 ratio, two hallmarks of apoptosis, were significantly decreased in the rats pre-treated with U0126 and PD169316, 7 days after Aβ injection. This observation was in agreement with the results of immunostaining analysis of the hippocampus that showed decreased levels of terminal transferase dUTP nick end labelling positive cells in the hippocampus of U0126 and PD169316 pre-treated rats, compared with the Aβ-injected group. We also chased the changes in the levels of calpain-2 and caspase-12, two ER factors, in the Aβ-injected and treatment groups. Decreased levels of calpain-2 and caspase-12 in U0126 and PD169316 pre-treated rats confirmed the protective effects of these inhibitors. Furthermore, we studied the effect of two stress-sensing transcription factors, nuclear-related factor-2 (Nrf2) and nuclear factor-кB (NF-кB), in Aβ-injected as wells as U0126 and PD169316 pre-treated rats. U0126 and PD169316 activated Nrf2 and suppressed NF-кB pathways, 7 days after Aβ injection. These antioxidant and inflammatory pathways restored to the vehicle level within 20 days. Taken together, our findings reinforce and extend the notion of the potential neuroprotective role of ERK and/or p38 inhibitors against the neuronal toxicity induced by Aβ.
机译:在本研究中,我们研究了脑室内给予细胞外信号调节蛋白激酶-(ERK)和p38特异性抑制剂U0126和PD169316对大鼠淀粉样蛋白β(Aβ)诱导的凋亡的影响。为了研究这些化合物的作用,我们评估了Aβ注射后7天和20天的凋亡的细胞内信号传导途径以及炎性和抗氧化剂途径。我们发现,在Aβ注射后7天,用U0126和PD169316预处理的大鼠中凋亡的两个标志物caspase-3和Bax / Bcl-2比率显着降低。该观察结果与海马的免疫染色分析结果相吻合,海马的免疫染色分析结果显示,与Aβ组相比,U0126和PD169316预处理大鼠海马中的末端转移酶dUTP缺口末端标记阳性细胞水平降低。我们还追踪了注射Aβ和治疗组的两个ER因子calpain-2和caspase-12的水平变化。 U0126和PD169316预处理的大鼠中calpain-2和caspase-12的水平降低证实了这些抑制剂的保护作用。此外,我们研究了两种压力感应转录因子,核相关因子2(Nrf2)和核因子-кB(NF-кB),在注射Aβ的小鼠以及U0126和PD169316预处理的大鼠中的作用。在注射Aβ后7天,U0126和PD169316激活Nrf2并抑制NF-кB通路。这些抗氧化剂和炎性途径可在20天内恢复至载体水平。两者合计,我们的发现加强和扩展了ERK和/或p38抑制剂对Aβ诱导的神经元毒性的潜在神经保护作用的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号